World's Best Scientists 2026 revealed!
VIEW LIST
Andrew D. Zelenetz

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 105 6695 6293 3535 3279 725 49816

Andrew D. Zelenetz publications per year

The chart shows the history of publications by Andrew D. Zelenetz between 1978 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Andrew D. Zelenetz published across 49 years, from 1978 to 2026, averaging 15.3 papers a year. Output peaked at 77 publications in 2023. 46 of the 751 publications appeared in the last two years.

No. of publications
25 50 75
Bar chart. Horizontal axis: year, 1978 to 2026. Vertical axis: number of publications, 0 to 77. Peak 77 publications in 2023. 1978: 1 publication 1979: 1 publication 1980: 2 publications 1981: 1 publication 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 1 publication 1987: 1 publication 1988: 0 publications 1989: 0 publications 1990: 2 publications 1991: 3 publications 1992: 5 publications 1993: 5 publications 1994: 0 publications 1995: 6 publications 1996: 1 publication 1997: 3 publications 1998: 3 publications 1999: 3 publications 2000: 12 publications 2001: 7 publications 2002: 5 publications 2003: 12 publications 2004: 27 publications 2005: 19 publications 2006: 21 publications 2007: 24 publications 2008: 13 publications 2009: 21 publications 2010: 28 publications 2011: 15 publications 2012: 22 publications 2013: 34 publications 2014: 45 publications 2015: 34 publications 2016: 38 publications 2017: 29 publications 2018: 14 publications 2019: 41 publications 2020: 32 publications 2021: 33 publications 2022: 33 publications 2023: 77 publications 2024: 31 publications 2025: 41 publications 2026: 5 publications
1978 2026

751 publications in total across all disciplines

View publications per year as a table
Andrew D. Zelenetz: publications per year, 1978 to 2026
Year Publications
1978 1
1979 1
1980 2
1981 1
1982 0
1983 0
1984 0
1985 0
1986 1
1987 1
1988 0
1989 0
1990 2
1991 3
1992 5
1993 5
1994 0
1995 6
1996 1
1997 3
1998 3
1999 3
2000 12
2001 7
2002 5
2003 12
2004 27
2005 19
2006 21
2007 24
2008 13
2009 21
2010 28
2011 15
2012 22
2013 34
2014 45
2015 34
2016 38
2017 29
2018 14
2019 41
2020 32
2021 33
2022 33
2023 77
2024 31
2025 41
2026 5
Total 751
Download as CSV

Andrew D. Zelenetz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andrew D. Zelenetz sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 721–740 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 725 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259 725
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Andrew D. Zelenetz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew D. Zelenetz sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 104–105 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 105 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513 105
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Andrew D. Zelenetz is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research activity is centered primarily within the field of Medicine, encompassing 481 publications. The subfields of study most represented in their work include Pathology and Forensic Medicine, Genetics, Oncology, Pulmonary and Respiratory Medicine, and Molecular Biology.

The main topics addressed in their research focus on Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, and CAR-T cell therapy research. Other areas of work include Viral-associated cancers and disorders, CNS Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, and Ovarian cancer diagnosis and treatment.

Frequent co-authors collaborating with Andrew D. Zelenetz include Gilles Salles, Paul A. Hamlin, Ariela Noy, Anita Kumar, and Lorenzo Falchi. These collaborations signify ongoing teamwork in related research domains.

The scientist has published extensively in a range of medical and oncological journals. The most frequent publication venues are Blood, Hematological Oncology, Journal of Clinical Oncology, Blood Advances, and Leukemia & lymphoma/Leukemia and lymphoma.

Some recent papers authored or co-authored by Andrew D. Zelenetz include:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee (2022, Blood)
  • Outcomes of COVID-19 in patients with CLL: a multicenter international experience (2020, Blood)
  • Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups (2020, Blood Cancer Journal)
  • Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma (2021, Journal of Clinical Oncology)
  • NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021 (2021, Journal of the National Comprehensive Cancer Network)

Best Publications

  • The 2016 revision of the World Health Organization classification of lymphoid neoplasms

    Steven H. Swerdlow;Elias Campo;Stefano A. Pileri;Nancy Lee Harris

  • Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.

    Richard R. Furman;Jeff P. Sharman;Steven E. Coutre;Bruce D. Cheson

  • Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

    Roland Schmitz;George W. Wright;Da Wei Huang;Calvin A. Johnson

  • Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.

    Kenneth R. Carson;Andrew M. Evens;Elizabeth A. Richey;Thomas M. Habermann

  • An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

    Zheng Zhou;Laurie H. Sehn;Alfred W. Rademaker;Leo I. Gordon

  • Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

    Carla Casulo;Michelle Byrtek;Keith L. Dawson;Xiaolei Zhou

  • Phase II Clinical Experience With the Novel Proteasome Inhibitor Bortezomib in Patients With Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

    Owen A. O'Connor;John Wright;Craig Moskowitz;Jamie Muzzy

  • Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas

    M. S. Kaminski;A. D. Zelenetz;O. W. Press;M. Saleh

  • Clinical Experience With Intravenous and Oral Formulations of the Novel Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Patients With Advanced Hematologic Malignancies

    Owen A. O'Connor;Mark L. Heaney;Lawrence Schwartz;Stacie Richardson

  • A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

    Craig H. Moskowitz;Stephen D. Nimer;Andrew D. Zelenetz;Tania Trippett

  • Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

    Tarun Kewalramani;Andrew D. Zelenetz;Stephen D. Nimer;Carol Portlock

  • Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

    Adam M Petrich;Mitul Gandhi;Borko Jovanovic;Jorge J Castillo

  • Non-Hodgkin's Lymphomas

    Andrew D. Zelenetz;Ranjana H. Advani;John C. Byrd;Myron S. Czuczman

  • Multicenter phase II study of iodine-131 tositumomab for chemotherapy- relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas

    Julie Marie Vose;Richard L. Wahl;Mansoor Saleh;Ama Z. Rohatiner

  • Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17).

    Jonathan D. Licht;Christine Chomienne;Andre Goy;Alex Chen

  • Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma

    Craig H. Moskowitz;Joseph R. Bertino;Jill R. Glassman;Eric E. Hedrick

  • NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.

    Zelenetz Ad;Abramson Js;Advani Rh;Andreadis Cb

  • Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma

    Craig H. Moskowitz;Heiko Schöder;Julie Teruya-Feldstein;Camelia Sima

  • Follicular Lymphoma in the United States: First Report of the National LymphoCare Study

    Jonathan W. Friedberg;Michael D. Taylor;James R. Cerhan;Christopher R. Flowers

  • Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease.

    David J. Straus;Carol S. Portlock;Jing Qin;Jane Myers

Frequent Co-Authors

Craig H. Moskowitz
Craig H. Moskowitz University of Miami
David J. Straus
David J. Straus Memorial Sloan Kettering Cancer Center
Joachim Yahalom
Joachim Yahalom Memorial Sloan Kettering Cancer Center
Anas Younes
Anas Younes AstraZeneca (United Kingdom)
Jonathan W. Friedberg
Jonathan W. Friedberg University of Rochester
Heiko Schöder
Heiko Schöder Memorial Sloan Kettering Cancer Center
Leo I. Gordon
Leo I. Gordon Northwestern University
Myron S. Czuczman
Myron S. Czuczman Citius Pharmaceuticals, Inc.
Julie M. Vose
Julie M. Vose University of Nebraska Medical Center
Ahmet Dogan
Ahmet Dogan Memorial Sloan Kettering Cancer Center

External Links

Personal website of Andrew D. Zelenetz

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine can open doors to a variety of related healthcare fields and professional pathways. Many students explore online degrees for flexibility and diverse options.

If you’re interested in shaping healthcare policies or managing medical facilities, a healthcare administration degree can provide the skills needed for leadership roles. For nurses aiming to advance their practice, there are adn to fnp bridge programs offering a streamlined transition from an Associate Degree in Nursing to becoming a Family Nurse Practitioner.

Nutrition is another vital field in healthcare. Pursuing an online bs in nutrition can pave the way for roles in wellness, preventive care, or dietetics. Those aspiring to executive positions in hospital or healthcare system management might consider cahme-accredited online mha programs, which are recognized for high standards in healthcare administration education.

Exploring these alternative degrees and career paths broadens options for students passionate about making a difference in healthcare beyond traditional medical school routes.

Best Scientists Citing Andrew D. Zelenetz

Gilles Salles

Gilles Salles

Memorial Sloan Kettering Cancer Center

Publications: 134

Pier Luigi Zinzani

Pier Luigi Zinzani

University of Bologna

Publications: 126

Christopher R. Flowers

Christopher R. Flowers

The University of Texas MD Anderson Cancer Center

Publications: 118

Jonathan W. Friedberg

Jonathan W. Friedberg

University of Rochester

Publications: 105

John F. Seymour

John F. Seymour

Peter MacCallum Cancer Centre

Publications: 102

Martin Dreyling

Martin Dreyling

Ludwig-Maximilians-Universität München

Publications: 100

Michael Hallek

Michael Hallek

University of Cologne

Publications: 100

Randy D. Gascoyne

Randy D. Gascoyne

BC Cancer Agency

Publications: 98

Bruce D. Cheson

Bruce D. Cheson

Georgetown University

Publications: 98

Julie M. Vose

Julie M. Vose

University of Nebraska Medical Center

Publications: 97

Stephen M. Ansell

Stephen M. Ansell

Mayo Clinic

Publications: 90

Oliver W. Press

Oliver W. Press

University of Washington

Publications: 87

Anas Younes

Anas Younes

AstraZeneca (United Kingdom)

Publications: 87

John P. Leonard

John P. Leonard

Cornell University

Publications: 81

L. Jeffrey Medeiros

L. Jeffrey Medeiros

The University of Texas MD Anderson Cancer Center

Publications: 77

Elias Campo

Elias Campo

University of Barcelona

Publications: 77

Trending Scientists

C. Suryanarayana

C. Suryanarayana

City University of Hong Kong

Xianlin Dong

Xianlin Dong

Chinese Academy of Sciences

Michael W. Bevan

Michael W. Bevan

John Innes Centre

Liang-Hu Qu

Liang-Hu Qu

Sun Yat-sen University

Igor B. Zhulin

Igor B. Zhulin

The Ohio State University

Johannes F. Imhoff

Johannes F. Imhoff

GEOMAR Helmholtz Centre for Ocean Research Kiel

Karl-Heinz Schleifer

Karl-Heinz Schleifer

Technical University of Munich

Shian-Jiann Lin

Shian-Jiann Lin

Geophysical Fluid Dynamics Laboratory

You-Kwan Oh

You-Kwan Oh

Pusan National University

N. Subba Rao

N. Subba Rao

Andhra University

Janine Wiles

Janine Wiles

University of Auckland

Andrea Corradini

Andrea Corradini

University of Pisa

Todd J. Martínez

Todd J. Martínez

Stanford University

Joao A.C. Lima

Joao A.C. Lima

Johns Hopkins University School of Medicine

Mark S. Litwin

Mark S. Litwin

University of California, Los Angeles

Ian Turner

Ian Turner

Queensland University of Technology

Related Medicine Rankings & Guides

2027 Best Online Bachelor’s Degrees in Nutritional Science Programs

2027 Best Online Bachelor’s Degrees in Nutritional Science Programs
2027 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus
2027 Best Online Associate Science in Nursing (ASN) Programs

2027 Best Online Associate Science in Nursing (ASN) Programs
2027 Best Online Nurse Practitioner Degree Programs

2027 Best Online Nurse Practitioner Degree Programs
2027 Most Affordable LPN/LVN to BSN Online Bridge Programs

2027 Most Affordable LPN/LVN to BSN Online Bridge Programs
2027 Most Affordable Online MSN in Nurse Executive Leadership Programs

2027 Most Affordable Online MSN in Nurse Executive Leadership Programs
September 2027 Best Online Certificate Program in Medical Office Administration: Guide to Online Degrees

September 2027 Best Online Certificate Program in Medical Office Administration: Guide to Online Degrees
September 2027 Best Online Doctorate in Pharmacy (PharmD.) Programs

September 2027 Best Online Doctorate in Pharmacy (PharmD.) Programs
2027 Best Nursing Schools in Texas – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Texas – Accredited ADN, BSN, MSN Programs
2027 Most Affordable Online Direct Entry MSN Programs for Non-Nurses

2027 Most Affordable Online Direct Entry MSN Programs for Non-Nurses
2027 Best Online Exercise Science Degree Programs

2027 Best Online Exercise Science Degree Programs
2027 Best PharmD Accelerated Degree Programs

2027 Best PharmD Accelerated Degree Programs
2027 Most Affordable Master’s in Health Science Degrees

2027 Most Affordable Master’s in Health Science Degrees
2027 Easiest Direct-Entry MSN Programs to Get Into

2027 Easiest Direct-Entry MSN Programs to Get Into
2027 Best Online CAHIIM-Accredited Health Information Management Degree Programs

2027 Best Online CAHIIM-Accredited Health Information Management Degree Programs
September 2027 Best Nursing Certifications to Consider

September 2027 Best Nursing Certifications to Consider
September 2027 Best Online Certificate Programs in Medical Billing & Coding Programs

September 2027 Best Online Certificate Programs in Medical Billing & Coding Programs
2027 Best Online Master’s in Clinical Research Programs

2027 Best Online Master’s in Clinical Research Programs
2027 Best Online CAHME-Accredited MHA Programs

2027 Best Online CAHME-Accredited MHA Programs
2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs
2027 Most Affordable Online AGNP Programs

2027 Most Affordable Online AGNP Programs

Recently Published Articles

2027 Is Liberal Arts a Hard Major? What Students Should Know

2027 Is Liberal Arts a Hard Major? What Students Should Know
2027 Self-Paced Online Logistics Degree Master's Programs

2027 Self-Paced Online Logistics Degree Master's Programs
2027 Online Software Engineering Doctorate Programs for Experienced Professionals Without Research Backgrounds

2027 Online Software Engineering Doctorate Programs for Experienced Professionals Without Research Backgrounds
2027 State Licensing Differences for Developmental Psychology Degree Graduates

2027 State Licensing Differences for Developmental Psychology Degree Graduates
2027 How to Become a Dialysis Technician – Salary & Requirements

2027 How to Become a Dialysis Technician – Salary & Requirements
2027 Online Sociology Degree Master's Programs That Accept Transfer Credits

2027 Online Sociology Degree Master's Programs That Accept Transfer Credits
2027 What Transfer Credits Matter Most in RN to BSN Admissions?

2027 What Transfer Credits Matter Most in RN to BSN Admissions?
2027 Geography Careers: Guide to Career Paths, Options & Salary

2027 Geography Careers: Guide to Career Paths, Options & Salary
2027 Psychology Degree Programs With Rolling Admissions

2027 Psychology Degree Programs With Rolling Admissions
2027 Can You Get Licensed With an Online Clinical Psychology Degree? Requirements, Rules, and What to Know

2027 Can You Get Licensed With an Online Clinical Psychology Degree? Requirements, Rules, and What to Know
2027 How to Pay for a Public Policy Master's Degree with Financial Aid

2027 How to Pay for a Public Policy Master's Degree with Financial Aid
2027 Best Accredited Schools for Social Work That Offer Multiple Degrees

2027 Best Accredited Schools for Social Work That Offer Multiple Degrees
2027 How to Pay for a Music Education Master's Degree with Financial Aid

2027 How to Pay for a Music Education Master's Degree with Financial Aid
2027 Different Types of Art History Bachelor's Degrees: Specializations, Careers, and Salaries

2027 Different Types of Art History Bachelor's Degrees: Specializations, Careers, and Salaries
2027 Best Accredited Online Esports Business Bachelor's Degree Programs

2027 Best Accredited Online Esports Business Bachelor's Degree Programs
2027 What Can You Do with an MFA in Creative Writing: Costs & Job Opportunities

2027 What Can You Do with an MFA in Creative Writing: Costs & Job Opportunities
2027 Which Health Informatics Degree Careers Offer the Best Return Without Graduate School?

2027 Which Health Informatics Degree Careers Offer the Best Return Without Graduate School?
2027 How to Become a Physical Therapist – Salary & Requirements

2027 How to Become a Physical Therapist – Salary & Requirements
2027 Best Nursing Schools in Washington, DC – Accredited Nursing Degree Programs Online

2027 Best Nursing Schools in Washington, DC – Accredited Nursing Degree Programs Online
2027 How to Become a Mental Health Counselor in New Jersey

2027 How to Become a Mental Health Counselor in New Jersey
2027 Substitute Teaching License & Requirements in Alabama

2027 Substitute Teaching License & Requirements in Alabama